Transnetyx
Bill Tempone has extensive experience in finance and leadership roles across various organizations. Currently serving as Executive Advisor at Transnetyx since October 2024, Bill previously held the position of Chief Financial Officer at Absolute Biotech from September 2023 to October 2024 and at Bioreclamation, LLC from January 2011 to September 2023. Earlier in the career, Bill worked as Senior Director of Finance at ICON Central Laboratories from August 1997 to December 2010, and as Financial Analyst at Barnes & Noble from 1995 to 1997. Bill Tempone earned a Bachelor’s degree in Accounting from St. Joseph's University New York between 1990 and 1995.
This person is not in any offices
Transnetyx
1 followers
Transnetyx is an automated genotyping company dedicated to serving research and saving time by removing redundant, yet necessary, tests conducted in genetic research. By optimizing resources, Transnetyx has paved the way for research to advance and deeper understandings to emerge. Founded in 2000 and headquartered in Memphis, Tenn., Transnetyx launched the world’s first fully-automated genotyping system for detecting transgenic, knockout, knock-in, SNP and CRISPR mutations in animal research models. Transnetyx has genotyped more than 25 million samples worldwide in 24 or 72 hours with 99.97 percent accuracy. It has built a genetic database of more than 20,000 assays and is the trusted genotyping resource for thousands of researchers in universities, hospitals and bioscience companies around the world. The mission of Transnetyx, then and now, is to help scientists accelerate research with fast, easy and accurate genotyping services. For more information, visit transnetyx.com. For current job openings, visit transnetyx.com/careers.